Artículos Comentados Endocrinología Pediátrica

Understanding the cause of type 2 diabetes. Taylor R.Lancet Diabetes And Endocrinol. 2024.doi:10.1016/s2213-8587(24)00157-8

Managing insulin resistance: the forgotten pathophysiological component of type 2 diabetesAbdul-Ghani M, Maffei P, DeFronzo RA.Lancet Diabetes Endocrinol. 2024 Aug 1:S2213-8587(24)00127-X. doi: 10.1016/S2213-8587(24)00127-X

Consensus Guidance for Monitoring Individuals With Islet Autoantibody–Positive Pre-Stage 3 Type 1 Phillip M, Achenbach P, Addala A et al.Diabetes. Diabetes Care. 2024. doi:10.2337/dci24-004

Genomic Considerations in the Treatment of Thyroid Carcinoma. Hattum CJ, Elsey RJ, Meissner T, Spanos WC. JCO Oncol Pract. 2024;20(7):873-875. https://www.doi.org/10.1200/OP.24.00198

Polycystic ovary syndromeStener-Victorin E, Teede H, Norman RJ, et al. PNat Rev Dis Primers. 2024 Apr 18;10(1):27.https://www.doi.org/10.1038/s41572-024-00511-3

Graves disease: latest understanding of pathogenesis and treatment options. Nat Rev Endocrinol. Lanzolla G, Marinò M, Menconi F. Published online July 22, 2024. doi:10.1038/s41574-024-01016-5

Reunión Clínica Julio 2024

Reuniones Clínicas AnterioresJulio​, 2024 VÍA STREAMING Unirse a la reunión Zoom: https://us06web.zoom.us/j/83412710923?pwd=TE9tdjNm aDVidnVrTS9NcVZUL2RiZz09 ID de reunión: 834 1271 0923 Código de acceso: 774703 T E M A R I O 10:00 – 10:45 horas CASO 1 “PANCREATITIS...

Continuous Subcutaneous Delivery of rhPTH(1-84) and rhPTH(1-34) by Pump in Adults With HypoparathyroidismCharoenngam N, Bove-Fenderson E, Wong D, el a.J Endocr Soc. 2024 Mar 29;8(5):bvae053. eCollection 2024 Mar 12.doi: 10.1210/jendso/bvae053

What Is Carcinoid Syndrome? A Critical Appraisal of Its Proposed MediatorsMulders MCF, de Herder WW, Hofland J.Endocr Rev. 2024 May 7;45(3):351-360. doi: 10.1210/endrev/bnad035